Prostate cancer (PCa) is a leading cause of male cancer-related death globally (1). The androgen receptor (AR) remains the main therapeutic target for lethal PCa, and although AR pathway inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback